BioCentury
ARTICLE | Company News

BioQuest, Biovector deal

April 17, 2000 7:00 AM UTC

The companies will evaluate the development of an HIV vaccine that combines HIVX's cocktail of HIV protein envelope peptides with Biovector's technology for delivering antigens in lipopeptide construc...